Sophie Houard has joined EVI in 2010 where she is the Director of Vaccine Development. She is responsible for overseeing pharmaceutical and subsequent production of vaccine candidates, as well as ad hoc clinical development.

Until 2001, she worked as a Scientific Researcher in the Molecular Parasitology Laboratory and Applied Genetics Laboratory of l’Université Libre de Bruxelles (ULB), before joining Henogen, Belgium as Chief Scientific Officer and Head of Henogen’s Proprietary Products Platform.  During the 2000s, she was in charge of the development of several biotech derived human drugs and vaccines.

She graduated with a master’s degree in Molecular Zoology from ULB, followed by a PhD in Sciences. She has more than 20 years of experience in GMP manufacturing and phase I-III clinical research of therapeutic drugs and prophylactic vaccines. She has submitted several successful patent applications and has authored and co-authored numerous scientific articles in peer reviewed journals.